Showing results (211-220 of 546) with videos related to
Sort By:
Pageof 55
Chest|July 24, 2008
New antithrombotic drugs: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)Jeffrey I Weitz, Jack Hirsh, Meyer M SamamaRevue Medicale De Bruxelles|July 1, 1995
[The treatment of deep venous thrombosis with low-molecular-weight heparin]M M Samama, A Achkar, M H HorellouThrombosis Research|September 3, 2014
Ex vivo reversal of the anticoagulant effects of edoxabanAbdel-Baset Halim, Meyer M Samama, Jeanne MendellActa Haematologica|September 11, 2001
The thrombophilic state in cancer patientsI Gouin-Thibault, A Achkar, M M SamamaThrombosis Research|October 1, 1982
Interactions of anticoagulant insoluble modified polystyrene resins with plasmatic proteinsC Fougnot, M Jozefowicz, L Bara, et al.Thrombosis Research|March 1, 1992
Correlation between anti-Xa and occurrence of thrombosis and haemorrhage in post-surgical patients treated with either Logiparin (LMWH) or unfractionated heparin. Post-surgery Logiparin Study GroupL Bara, A Leizorovicz, H Picolet, et al.Chest|September 24, 2004
New anticoagulant drugs: the Seventh ACCP Conference on Antithrombotic and Thrombolytic TherapyJeffrey I Weitz, Jack Hirsh, Meyer M SamamaJournal Des Maladies Vasculaires|January 1, 1992
[Erythrocyte aggregation and clinical course stages of venous insufficiency of the legs]F Zuccarelli, A Chabanel, A Taccoen, et al.Thrombosis and Haemostasis|September 2, 1991
Rapid aequorin loading into platelets in the presence of DMSO--characteristics of the responses (changes in light transmission and in calcium) to various agonistsF Potevin, T Lecompte, R Favier, et al.Journal Des Maladies Vasculaires|January 1, 1996
[Osteoporosis induced either by unfractionated heparin or by low molecular weight heparin]P Chigot, C De Gennes, M M SamamaPageof 55